Brain Dev 30:3142 Goldsteins G, Hakosalo V, Jaronen M, Keuters MH, Lehtonen , Koistinaho J (2022) CNS Redox Homeostasis and Dysfunction in Neurodegenerative Diseases.Antioxidants (Basel)11 Asslih S, Damri O, Agam G (2021) Neuroinflammation as a Common Denominator of Complex Diseases (Cancer, Diabetes Type 2, and Neuropsychiatric Disorders).Int J Mol Sci22 Nezu J, Tamai I, Oku A, Ohashi R, Yabuuchi H, Hashimoto N, Nikaido H, Sai Y, Koizumi A, Shoji Y, Takada G, Matsuishi T, Yoshino M, Kato H, Ohura T, Tsujimoto G, Hayakawa J, Shimane M, Tsuji A (1999) Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter
Archived from the original on 6 October 2015
It is also important to understand that adding a substance to the 503A Bulks List is not the same as completing the FDA drug approval process
Treadwell T, et al